Literature DB >> 12628947

Twenty-year survival after coronary artery surgery: an institutional perspective from Emory University.

William S Weintraub1, Stephen D Clements, L Van-Thomas Crisco, Robert A Guyton, Joseph M Craver, Ellis L Jones, Charles R Hatcher.   

Abstract

BACKGROUND: Coronary artery bypass graft (CABG) surgery has been performed frequently for symptomatic coronary atherosclerotic heart disease for more than 30 years. However, uncertainty exists regarding the relationship between long-term survival after CABG and readily available clinical correlates of mortality. METHODS AND
RESULTS: We studied outcome at 20 years by age, sex, and other variables in 3939 patients who had CABG surgery from 1973 to 1979 in the Emory University System of Healthcare. Twenty-year survival, freedom from myocardial infarction, and freedom from repeat CABG were 35.6% (95% confidence interval [CI], 33.9% to 37.3%), 66.6% (95% CI, 64.6% to 68.6%), and 59.1% (95% CI, 56.9% to 61.5%). Multivariate correlates of late mortality were age (hazard ratio [HR], 1.46 per 10 years), female sex (HR, 1.21), hypertension (HR, 1.44), angina class (HR, 1.07 per class increase of 1), prior CABG (HR, 1.72), ejection fraction (HR, 1.07 per 10-point decrease), number of vessels diseased (HR, 1.11 per 1-vessel increase), and weight (HR, 1.04 per 10 kg). Twenty-year survival by age was 55%, 38%, 22%, and 11% for age <50, 50 to 59, 60 to 69, and >70 years at the time of initial surgery. Survival at 20 years after surgery with and without hypertension was 27% and 41%, respectively. Similarly, 20-year survival was 37% and 29% for men and women.
CONCLUSIONS: Symptomatic coronary atherosclerotic heart disease requiring surgical revascularization is progressive with continuing events and mortality. Clinical correlates of mortality significantly impact survival over time and may help identify long-term benefits after CABG.

Entities:  

Mesh:

Year:  2003        PMID: 12628947     DOI: 10.1161/01.cir.0000053642.34528.d9

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Cardiac resynchronization therapy in patients undergoing open-chest cardiac surgery.

Authors:  Alberto Barosi; Maurizio Lunati; Giancarlo Speca; Alessandro Mazzola; Gabriele Paglino; Michele De Bonis; Saverio Iacopino; Mauro Cassese; Cosimo Damiano Dicandia; Giampiero Esposito; Marco Vimercati; Alberto Della Scala; Ettore Vitali
Journal:  J Interv Card Electrophysiol       Date:  2010-03-10       Impact factor: 1.900

2.  No-touch vein grafts and the destiny of venous revascularization in coronary artery bypass grafting-a 25th anniversary perspective.

Authors:  Ninos Samano; Michael Dashwood; Domingos Souza
Journal:  Ann Cardiothorac Surg       Date:  2018-09

3.  Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury.

Authors:  George E Havelka; Edward S Moreira; Monica P Rodriguez; Nick D Tsihlis; Zheng Wang; Janet Martínez; Joseph A Hrabie; Larry K Kiefer; Melina R Kibbe
Journal:  J Surg Res       Date:  2012-11-10       Impact factor: 2.192

4.  Adventitial contributions of the extracellular signal-regulated kinase and Akt pathways to neointimal hyperplasia.

Authors:  George E Havelka; Melissa E Hogg; Janet Martinez; Monisha N Banjeree; Qun Jiang; Melina R Kibbe
Journal:  Am J Surg       Date:  2011-09-09       Impact factor: 2.565

5.  Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry.

Authors:  Karen Okrainec; Louise Pilote; Robert Platt; Mark J Eisenberg
Journal:  Can J Cardiol       Date:  2006-08       Impact factor: 5.223

6.  Periadventitial adipose tissue modulates the effect of PROLI/NO on neointimal hyperplasia.

Authors:  Edward S M Bahnson; George E Havelka; Nathaniel C Koo; Qun Jiang; Melina R Kibbe
Journal:  J Surg Res       Date:  2016-07-05       Impact factor: 2.192

7.  Preoperative ejection fraction as a predictor of survival after coronary artery bypass grafting: comparison with a matched general population.

Authors:  Mohamed A Soliman Hamad; Albert H M van Straten; Jacques P A M Schönberger; Joost F ter Woorst; Andre M de Wolf; Elisabeth J Martens; André A J van Zundert
Journal:  J Cardiothorac Surg       Date:  2010-04-23       Impact factor: 1.637

8.  Prevalence and 1-year prognosis of transient heart failure following coronary revascularization.

Authors:  Marco Ambrosetti; Raffaele Griffo; Roberto Tramarin; Francesco Fattirolli; Pier Luigi Temporelli; Pompilio Faggiano; Stefania De Feo; Anna Rita Vestri; Francesco Giallauria; Cesare Greco
Journal:  Intern Emerg Med       Date:  2013-10-22       Impact factor: 3.397

9.  PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting.

Authors:  Izabela Wojtkowska; Andrzej Tysarowski; Katarzyna Seliga; Janusz A Siedlecki; Zbigniew Juraszyński; Milosz Marona; Lidia Greszata; Anna Skrobisz; Karol Kaminski; Robert Sawicki; Janina Stępińska
Journal:  PPAR Res       Date:  2014-10-13       Impact factor: 4.964

10.  Reduced Long-Term Relative Survival in Females and Younger Adults Undergoing Cardiac Surgery: A Prospective Cohort Study.

Authors:  Tone Bull Enger; Hilde Pleym; Roar Stenseth; Guri Greiff; Alexander Wahba; Vibeke Videm
Journal:  PLoS One       Date:  2016-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.